AFLAZIN capsules 0,3 g №30
Description AFLAZIN capsules 0,3 g:
• prevention of exacerbations of chronic urinary tract infections (UTI);
• prevention of UTI, including after instrumental intervention (endoscopic, radiological and gynecological research);
• acute and chronic UTI caused by sensitive to extract UTIRose ™ micro-organisms;
• UTI during pregnancy, starting from the 13th week of pregnancy;
• asymptomatic bacteriuria;
• prevention of formation of urinary concretions with an increase in urine pH, including after their removal.
Dosage and administration:
1 capsule 2 times a day regardless of meals. Duration of treatment is determined individually. If necessary AFLAZIN ™ can be used for a long time, repeated courses.
Hypersensitivity to any component.
Gestational age - up to 12 weeks inclusive.
If necessary, appropriate combination with antibacterial agents.
Conditions and terms:
In a dark place at temperatures from 40 C to 200 C.
Shelf life 2 years. Date of the expiration date indicated on the package.
Selective fitomolekuly ™
Selective fitomolekuly ™ - a modern generation of high-tech compounds of plant origin. This is the result of environmentally-friendly conditions of cultivation, scientific qualitative and quantitative selection of certain molecules, their standardization and a clinically proven effectiveness.
Unlike chemical agents selective fitomolekuly ™ does not harm the body, even after prolonged use and can be made pregnant. However, they do not concede, and sometimes exaggerate the effectiveness of synthetic substances, are therefore used as an alternative or a powerful complement the latter.
Unlike conventional plant foods contain selective fitomolekuly ™ unique patented molecular composition, efficacy and safety are proved by numerous studies in vivo.
UTIRose ™ - a representative of selective fitomolekul ™, designed for natural victory urinary tract infections, which contains a unique combination of flavonoids, proanthocyanidins, polysaccharides and organic acids, and is the result of years of research and visokospetsifichnih conditions of cultivation in the south of France.
Double placebo-controlled studies have shown high antimicrobial activity UTIRose ™ against such pathogens as Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter baumannii, Candida albicans. This activity is associated with the oxidation of urine, causing a bacteriostatic effect, and antiadgezivnymi properties of the extract, which prevents the adhesion (sticking) of microorganisms to the wall of the urinary tract, their development and reproduction. Exhibits anti-inflammatory, decongestant properties. Prevents the development of dizuricheskih phenomena.
Application UTIRose ™ is not accompanied by the development of resistance by microorganisms.